Canntab Therapeutics wins Health Canada hemp cultivation license

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCMKTS:CTABF) CFO Richard Goldstein tells Proactive Investors the Canadian company has achieved a major milestone by receiving a cultivation license from Health Canada.

The license allows Canntab to cultivate industrial hemp, said Goldstein adding it intends to use the license to secure hemp biomass that it will use to extract CBD to manufacture cannabis hard pills.

Related posts

Leave a Comment